title: EAS Consensus Panel statement on homozygous FH.
authors.affiliation: European Atherosclerosis Society, Mässans gata 18/Box 5243, SE-402 24 Gothenburg, Sweden. Electronic address: office@eas-society.org.
authors.forename: Jane
authors.initials: J
authors.lastname: Stock
mesh_terms: D048868:Adaptor Proteins, Signal Transducing / Q000235:genetics; D053299:Apolipoprotein B-100 / Q000235:genetics; D004252:DNA Mutational Analysis; D020022:Genetic Predisposition to Disease; D006720:Homozygote; D006801:Humans; D006938:Hyperlipoproteinemia Type II / Q000175:diagnosis / Q000235:genetics / Q000628:therapy; D009154:Mutation; D010641:Phenotype; D017410:Practice Guidelines as Topic; D011237:Predictive Value of Tests; D011379:Prognosis; D000071449:Proprotein Convertase 9; D043484:Proprotein Convertases / Q000235:genetics; D011973:Receptors, LDL / Q000235:genetics*; D012307:Risk Factors; D012697:Serine Endopeptidases / Q000235:genetics
chemical_list: C569471:APOB protein, human; D048868:Adaptor Proteins, Signal Transducing; D053299:Apolipoprotein B-100; C573412:LDLR protein, human; C469745:LDLRAP1 protein, human; D011973:Receptors, LDL; C472125:PCSK9 protein, human; D000071449:Proprotein Convertase 9; D043484:Proprotein Convertases; D012697:Serine Endopeptidases